Charity criticises 'delay' to new cancer unit
A cancer charity claims the opening of a planned new £2.5m specialist unit in Aberdeen has been delayed by at least a year.
Swift Urological Responsive Evaluation (Sure) is expected to improve diagnosis times for people with symptoms of urological cancers.
Ucan, which joined forces with Friends of Anchor to raise the money needed for the unit, said a change to where it would be located at Aberdeen Royal Infirmary had caused the delay.
NHS Grampian said it needed to ensure the unit "fitted neatly" with other services.
Urological cancers include prostate, penis and testicular cancer, as well as kidney and bladder.
More stories from North East Scotland, Orkney and Shetland
Listen to news from North East Scotland on BBC Sounds
It had been intended the unit would be within the current urology department.
But NHS Grampian said it was looking at setting it up in a different area of the hospital.
Ucan chief executive Kenny Anderson, who has himself been treated for prostate cancer, has expressed "disappointment" at the change from the original plan.
He said there were also ventilation concerns about the new location.
The new unit could be open from May next year.
NHS Grampian said it was crucial Sure was located in the right place.
A spokesperson said: "We have further examined the initial proposal, and the original space earmarked for the Sure unit.
"We note some concerns about the area identified, however once refurbished it will provide an excellent facility for the location of the Sure unit."
Planned cancer centre promises faster diagnosis
NHS Grampian
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
3 days ago
- Washington Post
How to manage ADHD at work and turn it into a strength
NEW YORK — Jeremy Didier had taken her son to a psychologist for a possible ADHD evaluation when she spotted an article about women with the condition. As she read it in the waiting room, she thought to herself: They're describing me. 'Lots of risk-taking, lots of very impulsive behavior growing up,' Didier said. As the magazine described, she'd excelled in school but gotten in trouble for talking too much. She'd amassed too many speeding tickets as an adult. She turned to her husband and said, 'I think I might have ADHD.'
Yahoo
19-06-2025
- Yahoo
New scanner used for brain tumour patients trialled in world-first
A 'pioneering' new scanner derived from MRI technology could be used to track brain cancer spread and lead to improved treatment for patients, researchers have said. Scientists at the University of Aberdeen and NHS Grampian have been awarded £350,000 of Scottish Government funding to generate never-before-seen images of glioblastoma brain tumours. The technology is hoped to potentially improve treatment and quality of life for patients, by investigating a new way to scan glioblastoma brain tumours – the most common and aggressive type, with more than 3,000 new patients in the UK diagnosed each year. Half of all patients die within 15 months of diagnosis even after extensive surgery, radiotherapy and chemotherapy. Field cycling imaging (FCI) is a new and specialist type of low-field MRI scan pioneered in Aberdeen and has already been found to be effective in detecting tumours in breast tissue and brain damage in stroke patients. It is hoped it can now be used to help brain tumour patients. MRI scanners were invented at the University of Aberdeen 50 years ago, but the new FCI scanner is the only one of its type used on patients anywhere in the world. The FCI derives from MRI but can work at low and ultra-low magnetic fields which means it is capable of seeing how organs are affected by diseases in ways that were previously not possible, and can vary the strength of the magnetic field during the patient's scan – acting like multiple scanners and extracting more information about the tissues. The new technology can detect tumours without having to inject dye into the body, which can be associated with kidney damage and allergic reactions in some patients. The team of doctors and scientists involved will scan glioblastoma patients undergoing chemotherapy after surgery and chemoradiotherapy. It is hoped the research will establish that, unlike conventional MRI scans, FCI can tell the difference between tumour growth and progression, and 'pseudo-progression' which looks like tumour but is not cancerous tissue, which could improve care and quality of life. Professor Anne Kiltie, Friends of ANCHOR chair in clinical oncology at the University of Aberdeen, who is leading the study said: 'We already have evidence that FCI is effective in detecting tumours in breast tissue and brain damage in patients following a stroke. 'Applying this exciting new technology to glioblastoma patients could give us a much more accurate and detailed picture of what is going on in their brain. 'If we can detect true tumour progression early, we can swap the patient to a potentially more beneficial type of chemotherapy. 'Also, being able to verify that a patient has pseudo-progression will prevent effective chemotherapy being stopped too early, because it was thought that the tumour has progressed, thus worsening prognosis. 'Providing certainty will also reduce anxiety for both patients and relatives and improve the quality of life of patients. 'Importantly, having a reliable method to identify progressive disease will allow development and more precise evaluation of emerging potential treatments. This is of particular importance as patients currently have a limited choice of treatments for combating their cancer. 'Ultimately, this study and related future work will improve quality, effectiveness and healthcare cost-effectiveness in the treatment of glioblastoma patients across Scotland and beyond.' Sarah-Jane Hogg, chief executive at Friends of ANCHOR, added: 'This is a really promising development and another example of the pioneering work coming out of the University of Aberdeen. 'Professor Kiltie's role at the University is fully funded by Friends of ANCHOR through our Dream Big appeal, and our thanks go to our donors and fundraisers for the part they've played in supporting this work.' A spokesperson for The Brain Tumour Charity said: 'This pioneering technology is a promising step forward for people who have been diagnosed with the most aggressive type of brain tumour. 'It's positive news in contrast to the accounts we often hear about delays to diagnosis, limited treatment options, and the struggle to get vital innovations to the NHS front line. 'We welcome this, and The Brain Tumour Charity will continue working with clinicians and policymakers in Scotland – and the rest of the UK – to help bring advances to patients more quickly.'
Health Line
06-06-2025
- Health Line
Seeing a Psychiatrist for the First Time
At first, I was scared and overwhelmed by the thought of seeing a psychiatrist. The first psychiatric evaluation is, in my experience, the most intense and lengthy of your entrance into the world of seeing a psychiatrist. I've been going to the psychiatrist for over 5 years. Read on for more about my experience. Initial appointment My evaluation was in person with my doctor (in early 2020, pre-pandemic), and my partner also came along as a support person to provide his insight and answer questions as needed. My psychiatrist manages a mental health program at a hospital, and that's how I got connected with him for my first appointment. There are many ways to find a psychiatrist. Many psychiatrists do not take insurance, but some do. Your insurance may also reimburse you, if that's part of your plan. If you pay out of pocket, it can be expensive: I've been quoted anywhere from $400+ for the initial intake. Follow-up appointments are usually cheaper, but still cost at least $100 each. Some specialty mental health programs receive grants that may make the appointments more affordable. Ahead of the appointment, you might be asked to complete a questionnaire to help your psychiatrist evaluate your symptoms. The questionnaires are usually about anxiety, depression, and more. You'll also provide your family medical history, or what you know of it. Completing the questionnaires may feel overwhelming, so it's a good idea take breaks as you work your way through them, if you are able. It may also feel scary. For me, I worried that the psychiatrist was going to discover a new diagnosis that I had not already been given. That's probably a typical trauma response: 'What is wrong with me? Am I broken? Will I always feel like this?' were all thoughts that I had when initially accepting that I needed a psychiatrist for my mental healthcare. My first appointment was close to an hour long and involved a long conversation with my doctor. I felt mentally drained and exhausted afterward, so I rested for the afternoon. A few years later, I can say that having a psychiatrist whom I trust has made all the difference in my ability to care for myself and my mental health. Follow-up appointments Follow-ups tend to be shorter, at about 30 minutes or less, depending on how you're feeling. My psychiatrist and I chat about my mood and the potential side effects of the medications. We discuss how things are going in my life, including work, socialization, exercise, sleep, hobbies, energy levels, and more. It's not a therapy appointment, but more like a check-in about overall wellness. Then, we discuss any potential medication modifications, and my psychiatrist answers questions that I may have. Appointment frequency with your psychiatrist will vary based on your care. Follow-ups with my psychiatrist are more routine now; I go four times a year. It's important to meet with them periodically, as needed, depending on how you're doing. If I've made a medication change, whether switching to a different medication or upping or lowering a dose, I'll meet with them more frequently to check in. I now meet with my psychiatrist via video, using an app the hospital system utilizes for secure connection.
